{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:31:25Z","timestamp":1791419485998,"version":"4.3.3"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Heart failure (HF) affects around 100 million people and is a staggering burden for health care system worldwide. Rapid and sustained activation of inflammatory response is an important feature of HF after myocardial infarction. Sympathetic overactivation is also an important factor in the occurrence and progression of HF. The beneficial effect of renal denervation (RDN) has been demonstrated in HF. In the current study, we hypothesized that RDN improves cardiac function in HF canine models due to acute myocardial infarction (AMI) and reduced inflammation might be involved. Twenty-four beagles were randomized into the control (n = 8), HF (n = 8), and HF + RDN group (n = 8). The HF model after AMI was established by embolization the anterior descending distal artery with anhydrous ethanol in the HF and HF + RDN group. Bilateral renal artery ablation was performed in the HF + RDN group. Cardiac function, serum creatine kinase, creatine kinase-MB and NT-Pro BNP level, and expression of inflammation-related proteins in myocardial were examined. Because the paraventricular nucleus of the hypothalamus might be involved in inflammation-induced central neural excitation in HF and plays an important role in regulating extracellular fluid volume and sympathetic activity, expression of inflammation-related proteins in hypothalamus was also examined. AMI and post-AMI HF model was created successfully. Compared with the HF group, dogs in the HF + RDN group showed better cardiac function 4 weeks after AMI: lower left ventricular end-diastolic pressure, left ventricular end-diastolic dimension, and left ventricular end-systolic dimension and higher LEVF and left ventricular systolic pressure (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05 for all) were observed in the HF + RDN group. In addition, dogs in the HF + RDN group had slightly less ventricular fibrosis. Interestingly, RDN had lower expression of inflammation-related proteins including interleukin-6, tumor necrosis factors-\u03b1, nuclear factor \u03baB, and monocyte chemotactic protein 1 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05 for all) in both myocardial tissue and hypothalamus. RDN can improve cardiac function in dogs with HF after myocardial infarction. Our results suggested that RDN might affect cytokine-induced central neural excitation in HF and later affect sympathetic activity. Our results suggested a potential beneficial mechanism of RDN independent of mechanism involving renal afferent and efferent sympathetic nerves.<\/jats:p>","DOI":"10.1097\/fjc.0000000000000899","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:03:46Z","timestamp":1598832226000},"page":"602-609","source":"Crossref","is-referenced-by-count":7,"title":["Effect of Renal Denervation on Cardiac Function and Inflammatory Factors in Heart Failure After Myocardial Infarction"],"prefix":"10.1097","volume":"76","author":[{"given":"Chao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasheng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"l223","DOI":"10.1136\/bmj.l223","article-title":"Trends in survival after a diagnosis of heart failure in the United Kingdom 2000\u20132017: population based cohort study","volume":"364","author":"Taylor","year":"2019","journal-title":"BMJ"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/eurheartj\/ehi184","article-title":"Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure","volume":"26","author":"Petersson","year":"2005","journal-title":"Eur Heart J."},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.CIR.73.4.615","article-title":"Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity","volume":"73","author":"Hasking","year":"1986","journal-title":"Circulation"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/HYPERTENSIONAHA.106.076083","article-title":"Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure","volume":"50","author":"Schultz","year":"2007","journal-title":"Hypertension"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.85.2.790","article-title":"Adrenergic effects on the biology of the adult mammalian cardiocyte","volume":"85","author":"Mann","year":"1992","journal-title":"Circulation"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0735-1097(95)00332-0","article-title":"Adverse consequences of high sympathetic nervous activity in the failing human heart","volume":"26","author":"Kaye","year":"1995","journal-title":"J Am Coll Cardiol."},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/01.CIR.93.9.1667","article-title":"Cardiac sympathetic nerve function in congestive heart failure","volume":"93","author":"Eisenhofer","year":"1996","journal-title":"Circulation"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jacc.2013.04.010","article-title":"Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis","volume":"62","author":"Davis","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial","volume":"376","author":"Investigators","year":"2010","journal-title":"Lancet"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.112.130880","article-title":"Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial","volume":"126","author":"Esler","year":"2012","journal-title":"Circulation"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2015.01.037","article-title":"12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial","volume":"65","author":"Bakris","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","article-title":"Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial","volume":"390","author":"Townsend","year":"2017","journal-title":"Lancet"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"46846","DOI":"10.18632\/oncotarget.15154","article-title":"Effects of renal denervation on monocrotaline induced pulmonary remodeling","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.hrthm.2014.01.024","article-title":"Interventional treatment of ventricular tachycardia and electrical storm: from ablation of substrate and triggers to autonomic modulation by renal denervation","volume":"11","author":"Lemery","year":"2014","journal-title":"Heart Rhythm"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/07853890.2017.1282168","article-title":"Renal sympathetic denervation for treatment of patients with heart failure: summary of the available evidence","volume":"49","author":"Nammas","year":"2017","journal-title":"Ann Med."},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"e009938","DOI":"10.1161\/JAHA.118.009938","article-title":"Renal denervation reduced ventricular arrhythmia after myocardial infarction by inhibiting sympathetic activity and remodeling","volume":"7","author":"Zhang","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jacc.2015.12.048","article-title":"Leukocytes link local and systemic inflammation in ischemic cardiovascular disease: an expanded \u201ccardiovascular continuum\u201d","volume":"67","author":"Libby","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","article-title":"Chronic heart failure and inflammation: what do we really know?","volume":"119","author":"Dick","year":"2016","journal-title":"Circ Res."},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurjhf\/hfn043","article-title":"Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology","volume":"11","author":"Heymans","year":"2009","journal-title":"Eur J Heart Fail."},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.93.4.704","article-title":"Tumor necrosis factor-\u03b1 and tumor necrosis factor receptors in the failing human heart","volume":"93","author":"Torre-Amione","year":"1996","journal-title":"Circulation"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","article-title":"Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study","volume":"107","author":"Vasan","year":"2003","journal-title":"Circulation"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00392-014-0773-4","article-title":"Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension","volume":"104","author":"D\u00f6rr","year":"2015","journal-title":"Clin Res Cardiol."},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306010","article-title":"Renal denervation prevents immune cell activation and renal inflammation in angiotensin II\u2013induced hypertension","volume":"117","author":"Xiao","year":"2015","journal-title":"Circ Res."},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/eurheartj\/eht331","article-title":"Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir","volume":"35","author":"van der Laan","year":"2013","journal-title":"Eur Heart J."},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1620\/tjem.222.251","article-title":"TNF-\u03b1 in hypothalamic paraventricular nucleus contributes to sympathoexcitation in heart failure by modulating AT1 receptor and neurotransmitters","volume":"222","author":"Kang","year":"2010","journal-title":"Tohoku J Exp Med."},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00395-011-0215-7","article-title":"NF-\u03baB in the paraventricular nucleus modulates neurotransmitters and contributes to sympathoexcitation in heart failure","volume":"106","author":"Kang","year":"2011","journal-title":"Basic Res Cardiol."},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/HYPERTENSIONAHA.115.06329","article-title":"Inhibition of brain mitogen-activated protein kinase signaling reduces central endoplasmic reticulum stress and inflammation and sympathetic nerve activity in heart failure rats","volume":"67","author":"Wei","year":"2016","journal-title":"Hypertension"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00380-010-0022-3","article-title":"A porcine model of ischemic heart failure produced by intracoronary injection of ethyl alcohol","volume":"26","author":"Kim","year":"2011","journal-title":"Heart Vessels"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s380-002-8317-8","article-title":"Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats","volume":"16","author":"Nozawa","year":"2002","journal-title":"Heart Vessels"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"e96996","DOI":"10.1371\/journal.pone.0096996","article-title":"A comparison of the efficacy of surgical renal denervation and pharmacologic therapies in post-myocardial infarction heart failure","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2012.09.019","article-title":"First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot Study","volume":"162","author":"Davies","year":"2013","journal-title":"Int J Cardiol."},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.1002\/ccd.26475","article-title":"Preliminary effects of renal denervation with saline irrigated catheter on cardiac systolic function in patients with heart failure: a prospective, randomized, controlled, pilot study","volume":"89","author":"Chen","year":"2017","journal-title":"Catheter Cardiovasc Interv."},{"key":"R34-20230915","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","article-title":"Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension","volume":"59","author":"Brandt","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"R35-20230915","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.CIR.0000081775.72651.B6","article-title":"Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy","volume":"108","author":"Schlaich","year":"2003","journal-title":"Circulation"},{"key":"R36-20230915","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/HYPERTENSIONAHA.116.08373","article-title":"Renal denervation reduces monocyte activation and monocyte\u2013platelet aggregate formation: an anti-inflammatory effect relevant for cardiovascular risk","volume":"69","author":"Zaldivia","year":"2017","journal-title":"Hypertension"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FJC.0000000000000899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T01:15:39Z","timestamp":1694740539000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FJC.0000000000000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0000000000000899","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}